Eisai To Resubmit Aricept Severe Alzheimer’s sNDA In December
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm is considering changing from paper to electronic filing to resolve formatting issues behind FDA’s refusal to file the sNDA.